Igene Biotechnology, Inc. (IGNE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Igene Biotechnology Revenue
Igene Biotechnology had revenue of $4.80K in the twelve months ending September 30, 2010, down -99.91% year-over-year. In the year 2009, Igene Biotechnology had annual revenue of $3.96M, down -48.23%.
Revenue (ttm)
4.80K
Revenue Growth
-99.91%
P/S Ratio
0.33
Revenue / Employee
266.89
Employees
18
Market Cap
1.57K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2009 | 3.96M | -3.69M | -48.23% |
Dec 31, 2008 | 7.64M | 5.36M | 234.30% |
Dec 31, 2007 | 2.29M | - | - |
Dec 31, 2006 | - | - | - |
Dec 31, 2005 | - | - | - |
Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 256.69M |
Chykingyoung Investment Development Holdings | 305.65K |
Panamera Holdings | 212.04K |
Rubber Leaf | 3.98M |
Cardinal Ethanol, LLC | 350.34M |
Venator Materials | 1.56B |